Lipoteichoic acid upregulates plasminogen activator inhibitor-1 expression in parapneumonic effusions-Reference-Cited by-同舟云学术

Lipoteichoic acid upregulates plasminogen activator inhibitor-1 expression in parapneumonic effusions

Published:2017-08-23 Issue:1 Volume:23 Page:89-95
ISSN:1323-7799
Container-title:Respirology
language:en
Short-container-title:Respirology

Author:

Lee Kai-Ling¹,Chen Wei-Lin²,Chen Ray-Jade³⁴,Lai Kevin S.¹,Chung Chi-Li¹⁵^ORCID

Affiliation:

1. Division of Pulmonary Medicine, Department of Internal Medicine; Taipei Medical University Hospital; Taipei Taiwan

2. Department of Nursing; Mackay Junior College of Medicine, Nursing, and Management; Taipei Taiwan

3. Department of Surgery, School of Medicine, College of Medicine; Taipei Medical University; Taipei Taiwan

4. Division of General Surgery, Department of Surgery; Taipei Medical University Hospital; Taipei Taiwan

5. Division of Thoracic Medicine, Department of Internal Medicine, School of Medicine and School of Respiratory Therapy, College of Medicine; Taipei Medical University; Taipei Taiwan

Funder

National Science Council

Taipei Medical University Hospital

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/resp.13148/fullpdf

Reference25 articles.

1. Pathogenesis of pleural infection;Hage;Respirology,2004

2. The mesothelial cell;Mutsaers;Int. J. Biochem. Cell Biol.,2004

3. Mesothelial cells: their structure, function and role in serosal repair;Mutsaers;Respirology,2002

4. Pathways of fibrin turnover of human pleural mesothelial cells in vitro;Idell;Am. J. Respir. Cell Mol. Biol.,1992

5. Cytokines and fibrinolytic enzymes in tuberculous and parapneumonic effusions;Lin;Clin. Immunol.,2005

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential Pneumococcal Growth Features in Severe Invasive Disease Manifestations;Microbiology Spectrum;2022-06-29

2. HDAC Inhibitor Abrogates LTA−Induced PAI-1 Expression in Pleural Mesothelial Cells and Attenuates Experimental Pleural Fibrosis;Pharmaceuticals;2021-06-18

3. Management of Pleural Infection;Pulmonary Therapy;2020-12-09

4. Pleural Empyema;Thoracic Surgery;2020

5. PAI-1 Level Differences in Malignant Plural Effusion, Parapneumonic Pleuritis, and Cardiac Hydrothorax;Medicina;2019-09-04